MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression implicated in various cancers.
• Prostate cancer progression is linked to altered miRNA expression profiles.
• Understanding novel miRNA roles is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role of miR-141-3p in prostate cancer.
• To identify the downstream targets and mechanisms of miR-141-3p in prostate tumorigenesis.
• To evaluate miR-141-3p and KLF9 as potential therapeutic targets.

Main Methods:

• Quantitative real-time PCR to measure miR-141-3p and KLF9 expression.
• Cell proliferation and spheroid formation assays in prostate cancer cell lines (PC-3).
• Western blotting to assess protein levels of stemness factors and KLF9.
• Bioinformatic analysis and luciferase reporter assays to confirm direct targeting of KLF9 by miR-141-3p.

Main Results:

• miR-141-3p was significantly upregulated in prostate cancer cells and tissues.
• Overexpression of miR-141-3p promoted proliferation and stemness in PC-3 cells.
• miR-141-3p directly suppressed Kruppel-like factor-9 (KLF9) expression by binding to its 3'-UTR.
• Downregulation of KLF9 by miR-141-3p enhanced prostate cancer cell stemness and tumorigenesis.

Conclusions:

• miR-141-3p acts as an oncogenic miRNA in prostate cancer, promoting tumorigenesis and stemness.
• The miR-141-3p/KLF9 axis is a critical regulator of prostate cancer growth.
• Targeting the miR-141-3p/KLF9 pathway may offer a novel therapeutic strategy for prostate cancer.